Serum leptin levels correlate with interleukin‐6 levels and disease activity in patients with ankylosing spondylitis
Authors:
- M‐C. ParkMPM‐C. Park
- S‐W. LeeSLS‐W. Lee
- S‐T. ChoiSCS‐T. Choi
- Y‐B. ParkYPY‐B. Park
- S‐K. LeeSLS‐K. Lee
- 1 January 2007
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 36 (2) , 101-106
Abstract
To determine whether serum leptin levels are elevated in men with ankylosing spondylitis (AS) and whether the levels correlate with serum cytokine profiles and disease activity of AS. Forty-two male patients with newly diagnosed AS were enrolled. Their Bath AS Disease Activity Index (BASDAI), body mass index (BMI), and acute phase reactants, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels, were assessed. Serum leptin levels were determined using radioimmunoassay (RIA) and serum cytokine profiles, including tumour necrosis factor (TNF)-alpha, interleukin (IL)-6, and interferon (IFN)-gamma, were determined using enzyme-linked immunosorbent assay (ELISA). These results were compared with those from 42 age-matched healthy men. After a follow-up period of 31.0+/-20.1 months, clinical and biochemical variables were reassessed in the men with AS. At baseline, patients with AS had significantly elevated serum levels of leptin, leptin adjusted for BMI (leptin/BMI), TNFalpha, and IL-6, but not IFN-gamma, as compared to the controls. Serum leptin/BMI levels correlated well with IL-6 levels, and both leptin/BMI and IL-6 levels correlated well with BASDAI and CRP levels in patients with AS. The changes in leptin/BMI and IL-6 levels between the baseline and follow-up measurements correlated well with one another (p<0.05) and both correlated well with the changes in BASDAI (p<0.05). Serum leptin/BMI levels were increased and significantly associated with IL-6 levels and disease activity in men with AS, suggesting a possible role for leptin in the inflammatory reactions of AS.Keywords
This publication has 28 references indexed in Scilit:
- Preferential type 1 chemokine receptors and cytokine production of CD28− T cells in ankylosing spondylitisAnnals of the Rheumatic Diseases, 2006
- Therapy of ankylosing spondylitis – a review. Part I: Conventional medical treatment and surgical therapyScandinavian Journal of Rheumatology, 2005
- Leptin regulation of the immune response and the immunodeficiency of malnutrition 1The FASEB Journal, 2001
- Human Leptin Stimulates Proliferation and Activation of Human Circulating MonocytesCellular Immunology, 1999
- Leptin Is an Endogenous Protective Protein against the Toxicity Exerted by Tumor Necrosis FactorJournal of Experimental Medicine, 1999
- Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory AnorexiaJournal of Experimental Medicine, 1997
- Identification and expression cloning of a leptin receptor, OB-RCell, 1995
- Positional cloning of the mouse obese gene and its human homologueNature, 1994
- SERUM CYTOKINES (IL-6, TNF-α, IL-1β AND IFN-γ) IN ANKYLOSING SPONDYLITIS: A CLOSE CORRELATION BETWEEN SERUM IL-6 AND DISEASE ACTIVITY AND SEVERITYRheumatology, 1994
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984